Wells Fargo & Company Issues Pessimistic Forecast for Bio-Rad Laboratories (NYSE:BIO) Stock Price
Bio-Rad Laboratories (NYSE:BIO – Free Report) had its target price reduced by Wells Fargo & Company from $320.00 to $270.00 in a research note released on Thursday,Benzinga reports. They currently have an equal weight rating on the medical research company’s stock. Several other equities analysts also recently weighed in on BIO. StockNews.com downgraded shares of […]
Bio-Rad Laboratories (NYSE:BIO – Free Report) had its target price reduced by Wells Fargo & Company from $320.00 to $270.00 in a research note released on Thursday,Benzinga reports. They currently have an equal weight rating on the medical research company’s stock. Several other equities analysts also recently weighed in on BIO. StockNews.com downgraded shares of […]
